Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Chronic Disease
|
May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis
Annemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Orphanet Journal of Rare Diseases
|
September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Nature Genetics
|
July 26, 2003
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification
Frank Rutsch, Nico Ruf, Sucheta Vaingankar, et al.
Nature Reviews. Nephrology
|
February 5, 2025
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner, Francesco Emma, Lothar Seefried, et al.
Nature Reviews. Nephrology
|
January 15, 2025
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner, Francesco Emma, Lothar Seefried, et al.
Plos One
|
March 20, 2026
The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis
Vrinda Saraff, Pedro Arango Sancho, Justine Bacchetta, et al.
Hormone Research in Paediatrics
|
January 8, 2026
Longitudinal Observation of Children With Achondroplasia: Findings From a Global Natural History Study (ACHieve)
Ciara McDonnell, Hanne Buciek Hove, Melita Irving, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 25, 2023
Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia
Annika Ewert, Mirko Rehberg, Karl Peter Schlingmann, et al.
Kidney International
|
October 26, 2024
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c
Max Brunkhorst, Lena Brunkhorst, Helge Martens, et al.
European Journal of Endocrinology
|
June 23, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia
Signe Sparre Beck-Nielsen, Gema Ariceta, Annemieke M Boot, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Chronic Disease
|
May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis
Annemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Orphanet Journal of Rare Diseases
|
September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Nature Genetics
|
July 26, 2003
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification
Frank Rutsch, Nico Ruf, Sucheta Vaingankar, et al.
Nature Reviews. Nephrology
|
February 5, 2025
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner, Francesco Emma, Lothar Seefried, et al.
Nature Reviews. Nephrology
|
January 15, 2025
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner, Francesco Emma, Lothar Seefried, et al.
Plos One
|
March 20, 2026
The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis
Vrinda Saraff, Pedro Arango Sancho, Justine Bacchetta, et al.
Hormone Research in Paediatrics
|
January 8, 2026
Longitudinal Observation of Children With Achondroplasia: Findings From a Global Natural History Study (ACHieve)
Ciara McDonnell, Hanne Buciek Hove, Melita Irving, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 25, 2023
Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia
Annika Ewert, Mirko Rehberg, Karl Peter Schlingmann, et al.
Kidney International
|
October 26, 2024
Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c
Max Brunkhorst, Lena Brunkhorst, Helge Martens, et al.
European Journal of Endocrinology
|
June 23, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia
Signe Sparre Beck-Nielsen, Gema Ariceta, Annemieke M Boot, et al.
Page
of 8